Member Info for shandypants2

Rightmove has just reported 30% increase in traffic so hopefully OTMP has done similar, possibly more with the new advertising campaign.
If so hoping the YE figures may exceed the Nov update. Should know in a few weeks.
Govt March mini budget will be interesting too - hoping for the zero stamp duty to be extended.

great update but cash burn is still a concern. The loan facility is £3m and we have already drawn half, hence why we have £1.5m cash - without this we would have zero cash. Also had an earlier loan of £400k.

All looking good though and merger offers excellent opportunities

really disappointing and agree a placing looks inevitable now.

Can also see Life Sciences being sold off at a big loss

SH
1) there are loads of cheap iron tablets, but they don't work for 95% of people hence the only alternative is an expensive hospital administer IV. Feraccru sits between the 2 and is priced accordingly
2)we have partners in Europe and China so there is demand for the product. The US delays have been very frustrating, but suspect shareholders will never be given the details. Two US companies recently dropped out due to issues at their end (one failed a phase 3 trail on its main product).
3) agree - but it is only being sold in 2 countries ATM

It appears sensible to wait for funding, however, funding is only 1 option STX are looking at. They are in negotiations with 2 additional US companies so if these are successfully concluded the placing option is not required - and the share price will probably be a lot higher!

YE trading update in the next few weeks. If guided £60m (from Nov updated guidance) is bettered then can see this getting re-rated.
Growing, profitable and generating cash.

yes, it was a how to make it commercial, not if, so all bodes well going forward

and we've been waiting for MHRA approval for months - just get it done.

After each vaccination give the patient a home test and tell them to do it in 4 weeks time.

Why has a **** lateral flow test (innova) been approved and is being used in schools as i type, yet a cheap and reliable antibody test that govt has part funded is still gathering dust?

How else will people know if the vaccine has been effective?? The test has been developed in parallel with the oxford/astra vaccine

big 50k purchase reported late yesterday.

Probably a H1 2020 trading update next week.
Think we did £5.1m rev last year. Anything similar will be ok IMHO as retail must still be quite low. Cash position also important so all eyes on that.

With new CEO in place strategic direction going forward will be interesting.

https://www.bbc.co.uk/news/uk-wales-55579028

no vaccine is 100% effective and spacing out the 2 doses is clearly less effective.
Some people will still get covid despite having a vaccine and we know that vulnerable/old people have less efficient immune systems.
Give everyone a antibody test 4 weeks after the first dose is surely the answer. We have the tests, we just need Sage/the Govt to join the dots, and quickly

so how will you know if the vaccine has been successful for vulnerable people? Oh that's right a self administered antibody test

well i reckon after a positive trading/end of year update in early Feb and maybe an extension to the zero stamp duty period and your share will be worth 150p soon!

well dflynch the fact that you've gone back over 50 years to quote flu deaths, surely answers your own question.

Usually a bad flu will kill c20k people in the UK, all with underlying health conditions.

Covid is already at c80k (and that's with a positive test - surely there are others who died without a test) and will sadly be over 100k in the next few months. It is clear worse

Uddin , first post on STX?

Feraccru as a product is fantastic and there will be global revenues generated in the next few years.

The £30m is over a 2 year period and is the worst case scenario - they are currently in discussions with 2 US companies who have remade contact with STX.
As per Dec 2020 presentation thinking is 50% debt and 50% placing so the raise will be maximum £15m.

European rev should start increasing as currently only sold in 2 countries - soon to expand to 5 , and China rev should start in 2023 as will a 8 figure $ milestone payment.

It's not all bad news - at these prices i'd say it's low/average risk for high reward

SATAN - what a joke you are.

Many of the contracts issued by the govt are to mates with no history/knowledge of PPE/medical supplies.
Surely they should be held to account - after all it is tax payers money.
From what i am aware of Jolyon Maugham has taken a massive pay cut to investigate these cases, he did kill 1 fox, that got injured in his garden, and he believes he has paid the builders in full.

So what is your point? Are you a covid denier too?

oil now at over $54 p.b - let's get the $73m outstanding repayment terms sorted asap now .

I'd take an extra $5m a month so full payment received in a little over 1 year

just to add to the debate, Goldman Sachs has announced that once vaccines have been rolled they will consider getting staff back into the office.

This got me thinking that as vaccines aren't 100% effective, especially the Oxford one, and the gap between the 2 injections may not be ideal, then having a vaccine alone may not be sufficient to give full immunity.

What will give companies confidence? A quick , cheap antibody test to show that the person vaccinated has the antibodies to protect him/her . So in six months or so the antibody test could essentially become the 'passport' required to open up the economy

agree - this is summed up by Hardman's comment...

The shares have over-reacted to the “lack of deal” news and should recover quickly once the uncertainty is removed.

liked that write up and totally agree. Small company, now making a profit and now also advertising on TV.
Very undervalued in comparison with peer (Rightmove) too,

Guessing lockdown will have a short term impact but surprised at share price performance last few days.

Thought we'd be nearer 150p IMHO. I've topped up

now the dust has settled on the Dec announcement the next few months for STX and in particular the CEO are critical.

At today's price STX is clearly undervalued, however, with low European revenue and no China revenue for the next 2 years sells in the US, the biggest market by a significant amount, are critical.
After nearly 18 months we are still no further forward which is massively frustrating .

So what could happen in the next few months?
1. progress with the 2 US companies who re-approached STX recently
2. progress on go it alone option and how this is funded
3. potentially a mix of 1 and 2 - potentially a better way forward
4. potential takeover - could probably pick STX up at 50% less than this time last year
5. progress with access to additional European markets - this has been slow, partly due to the H2H study debaucle
6. Deals in other regions - Japan, Australia etc

So hopefully it's not all doom and gloom if the BOD get their act together

hopefully the bad news is out of the way now and Tony can get on and start delivering now. Maybe the increase today is the start of a share rise.
Cost of production is c$200 per tonne and i think it will sell at around 100% more than that so still a decent profit to be made
Found this article from last year - quite interesting
https://www.proactiveinvestors.com.au/companies/news/221335/sulphate-of-potash-an-agricultural-phenomenon-within-the-mining-industry-221335.html